|
CN1856576B
(zh)
|
2003-09-30 |
2011-05-04 |
宾夕法尼亚州立大学托管会 |
腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
|
|
US8632764B2
(en)
|
2008-04-30 |
2014-01-21 |
University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
|
EP2396343B1
(en)
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
WO2012109570A1
(en)
*
|
2011-02-10 |
2012-08-16 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
|
HRP20171334T1
(hr)
|
2011-04-22 |
2017-11-17 |
The Regents Of The University Of California |
Virioni adeno-povezanog virusa s kapsid varijantom i postupci njihove upotrebe
|
|
ES2857773T5
(es)
|
2011-08-24 |
2024-06-04 |
Univ Leland Stanford Junior |
Nuevas proteínas de la cápside de AAV para la transferencia de ácidos nucleicos
|
|
WO2013170078A1
(en)
|
2012-05-09 |
2013-11-14 |
Oregon Health & Science University |
Adeno associated virus plasmids and vectors
|
|
KR20240090694A
(ko)
*
|
2013-07-22 |
2024-06-21 |
더 칠드런스 호스피탈 오브 필라델피아 |
변종 ａａｖ 및 조성물, 세포, 기관 및 조직으로의 유전자 전이를 위한 방법 및 용도
|
|
US9585971B2
(en)
|
2013-09-13 |
2017-03-07 |
California Institute Of Technology |
Recombinant AAV capsid protein
|
|
WO2015048534A1
(en)
|
2013-09-26 |
2015-04-02 |
University Of Florida Research Foundation, Inc. |
Synthetic combinatorial aav capsid library for targeted gene therapy
|
|
WO2015164757A1
(en)
|
2014-04-25 |
2015-10-29 |
Oregon Health & Science University |
Methods of viral neutralizing antibody epitope mapping
|
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
MY187898A
(en)
*
|
2015-03-02 |
2021-10-27 |
Adverum Biotechnologies Inc |
Compositions and methods for intravitreal delivery of polynucleotides to retinal cones
|
|
US20190000940A1
(en)
|
2015-07-31 |
2019-01-03 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of aadc deficiency
|
|
BR112018003665A2
(en)
|
2015-09-28 |
2018-09-25 |
The University Of North Carolina At Chapel Hill |
methods and compositions for antibody evasion viral vectors
|
|
KR102423442B1
(ko)
|
2015-12-11 |
2022-07-20 |
캘리포니아 인스티튜트 오브 테크놀로지 |
아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드
|
|
EP3448875A4
(en)
|
2016-04-29 |
2020-04-08 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
EP3448987A4
(en)
|
2016-04-29 |
2020-05-27 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
FI3445773T3
(fi)
|
2016-05-13 |
2023-03-30 |
4D Molecular Therapeutics Inc |
Adenoassosioituneen viruksen kapsidimuunnoksia ja niiden käyttömenetelmiä
|
|
CA3024449A1
(en)
|
2016-05-18 |
2017-11-23 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating huntington's disease
|
|
EP3827812B1
(en)
|
2016-07-29 |
2025-10-29 |
The Regents of the University of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
|
EP3526333A4
(en)
|
2016-10-13 |
2020-07-29 |
University of Massachusetts |
AAV CAPSIDE DESIGNS
|
|
CA3040179A1
(en)
|
2016-10-19 |
2018-04-26 |
Adverum Biotechnologies, Inc. |
Modified aav capsids and uses thereof
|
|
AU2018224044B2
(en)
|
2017-02-21 |
2024-01-25 |
The Uab Research Foundation |
Modified AAV capsid proteins and uses thereof
|
|
CA3052487A1
(en)
*
|
2017-02-28 |
2018-09-07 |
The Trustees Of The University Of Pennsylvania |
Influenza vaccines based on aav vectors
|
|
SG11201907762RA
(en)
|
2017-03-24 |
2019-10-30 |
Nat Univ Singapore |
Methods for multiplex detection of molecules
|
|
US20200370039A1
(en)
|
2017-04-11 |
2020-11-26 |
Ruprecht-Karls-Universitat Heidelberg |
Adeno-associated virus library
|
|
JP2020518266A
(ja)
|
2017-05-05 |
2020-06-25 |
ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
調節性ポリヌクレオチド
|
|
EP3618839A4
(en)
|
2017-05-05 |
2021-06-09 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
JP2020518259A
(ja)
|
2017-05-05 |
2020-06-25 |
ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
ハンチントン病治療組成物および方法
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
WO2019006182A1
(en)
|
2017-06-30 |
2019-01-03 |
The Regents Of The University Of California |
VIRIONS OF ADENO-ASSOCIATED VIRUSES OF CAPSID VARIANTS AND METHODS OF USE THEREOF
|
|
JP7221275B2
(ja)
|
2017-08-03 |
2023-02-13 |
ボイジャー セラピューティクス インコーポレイテッド |
Ａａｖを送達するための組成物および方法
|
|
SG11202002276VA
(en)
|
2017-09-20 |
2020-04-29 |
4D Molecular Therapeutics Inc |
Adeno-associated virus variant capsids and methods of use thereof
|
|
NZ763617A
(en)
|
2017-10-16 |
2026-01-30 |
Vigeneron Gmbh |
Aav vectors
|
|
DK3717636T5
(da)
|
2017-11-27 |
2024-08-26 |
4D Molecular Therapeutics Inc |
Adeno-associeret-virus-variantcapsider og anvendelse til inhibering af angiogenese
|
|
SG11202006056RA
(en)
|
2018-01-17 |
2020-07-29 |
Meiragtx Uk Ii Ltd |
A modified raav capsid protein for gene therapy
|
|
CN112105630A
(zh)
|
2018-02-15 |
2020-12-18 |
T·比约尔克隆德 |
经修饰的病毒衣壳
|
|
BR112020016699A2
(pt)
|
2018-02-28 |
2020-12-15 |
The University Of North Carolina At Chapel Hill |
Métodos e composições para vetores de vírus de evasão de anticorpos
|
|
US11608510B2
(en)
|
2018-03-30 |
2023-03-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Recombinant adeno-associated virus capsids with enhanced human pancreatic tropism
|
|
CN112543766A
(zh)
|
2018-04-03 |
2021-03-23 |
斯特里迪比奥公司 |
抗体逃避性病毒载体
|
|
CA3094465A1
(en)
|
2018-04-03 |
2019-10-10 |
Stridebio, Inc. |
Virus vectors for targeting ophthalmic tissues
|
|
US20210363191A1
(en)
|
2018-04-03 |
2021-11-25 |
Stridebio, Inc. |
Antibody-evading virus vectors
|
|
AU2019258830B2
(en)
|
2018-04-27 |
2025-12-18 |
Universität Heidelberg |
Modified AAV capsid polypeptides for treatment of muscular diseases
|
|
WO2019210267A2
(en)
|
2018-04-27 |
2019-10-31 |
Spark Therapeutics, Inc. |
Engineered aav capsids with increased tropism and aav vectors comprising the engineered capsids and methods of making and using same
|
|
IL278598B2
(en)
|
2018-05-11 |
2025-11-01 |
Massachusetts Eye & Ear Infirmary |
Altering tissue tropism of adeno-associated viruses
|
|
SG11202011296VA
(en)
|
2018-05-15 |
2020-12-30 |
Voyager Therapeutics Inc |
Compositions and methods for the treatment of parkinson's disease
|
|
TW202015742A
(zh)
|
2018-05-15 |
2020-05-01 |
美商航海家醫療公司 |
投遞腺相關病毒（ａａｖ）之組成物和方法
|
|
US12338267B2
(en)
|
2018-05-15 |
2025-06-24 |
President And Fellows Of Harvard College |
Viral vectors exhibiting improved gene delivery properties
|
|
US20210207167A1
(en)
|
2018-05-16 |
2021-07-08 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
|
CN112566923B
(zh)
|
2018-06-12 |
2024-10-29 |
北卡罗来纳大学教堂山分校 |
合成嗜肝性腺相关病毒衣壳及其用途
|
|
US20210261962A1
(en)
|
2018-06-21 |
2021-08-26 |
The Board Of Regents Of The University Of Texas System |
Correction of dystrophin exon 43, exon 45, or exon 52 deletions in duchenne muscular dystrophy
|
|
CN112703198B
(zh)
|
2018-07-11 |
2025-05-30 |
布里格姆妇女医院 |
用于跨血脑屏障递送试剂的方法和组合物
|
|
US20210277418A1
(en)
|
2018-08-03 |
2021-09-09 |
Voyager Therapeutics, Inc. |
Aav variants with enhanced tropism
|
|
WO2020068990A1
(en)
*
|
2018-09-26 |
2020-04-02 |
California Institute Of Technology |
Adeno-associated virus compositions for targeted gene therapy
|
|
US12281321B2
(en)
|
2018-09-28 |
2025-04-22 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
EP3861010A1
(en)
|
2018-10-02 |
2021-08-11 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
|
WO2020077165A1
(en)
|
2018-10-12 |
2020-04-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
WO2020142714A1
(en)
|
2019-01-04 |
2020-07-09 |
Exonics Therapeutics, Inc. |
Aav expression cassette and aav vectors comprising the same
|
|
JP2022522995A
(ja)
|
2019-01-18 |
2022-04-21 |
ボイジャー セラピューティクス インコーポレイテッド |
Ａａｖ粒子を生成するための方法及びシステム
|
|
EP3917945A4
(en)
|
2019-01-30 |
2023-02-08 |
The Broad Institute Inc. |
ADVANCED ADENO-ASSOCIATED VIRUS (AAVS) TARGETED DELIVERY SYSTEMS
|
|
US11718834B2
(en)
|
2019-02-15 |
2023-08-08 |
Sangamo Therapeutics, Inc. |
Compositions and methods for producing recombinant AAV
|
|
BR112021018776A2
(pt)
|
2019-03-21 |
2021-11-30 |
Stridebio Inc |
Vetores de vírus adenoassociado recombinante
|
|
MX2021011701A
(es)
|
2019-03-28 |
2021-12-10 |
Massachusetts Gen Hospital |
Vectores adenoasociados fabricados por ingenieria (aav) para expresion transgenica.
|
|
EP3715358A1
(en)
|
2019-03-28 |
2020-09-30 |
Universität zu Köln |
Mutated adeno-associated virus capsid proteins, aav particle comprising the same and liver directed aav vector gene therapy
|
|
CN114450411A
(zh)
|
2019-04-01 |
2022-05-06 |
特纳亚治疗股份有限公司 |
具有工程化衣壳的腺相关病毒
|
|
TW202102526A
(zh)
|
2019-04-04 |
2021-01-16 |
美商銳進科斯生物股份有限公司 |
重組腺相關病毒及其用途
|
|
AU2020271108A1
(en)
|
2019-04-11 |
2021-11-11 |
California Institute Of Technology |
Virus compositions with enhanced specificity in the brain
|
|
CN114127088B
(zh)
|
2019-04-23 |
2024-05-14 |
国家医疗保健研究所 |
变体衣壳蛋白和腺相关病毒aav变体及其药物组合物
|
|
EP3959226A2
(en)
|
2019-04-26 |
2022-03-02 |
Sangamo Therapeutics, Inc. |
Engineering aav
|
|
WO2020223276A1
(en)
|
2019-04-29 |
2020-11-05 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tauopathy
|
|
WO2020223280A1
(en)
|
2019-04-29 |
2020-11-05 |
Voyager Therapeutics, Inc. |
Aav variants with enhanced tropism
|
|
WO2020223279A1
(en)
|
2019-04-29 |
2020-11-05 |
Voyager Therapeutics, Inc. |
VECTORIZED ANTIBODIES (vAb) AND USES THEREOF
|
|
WO2020227515A1
(en)
|
2019-05-07 |
2020-11-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation
|
|
WO2021007382A1
(en)
|
2019-07-09 |
2021-01-14 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of parkinson's disease
|
|
PL3999119T3
(pl)
|
2019-07-15 |
2025-02-10 |
Meiragtx Uk Ii Limited |
Modyfikowane białka kapsydu aav do leczenia choroby zapalnej stawów
|
|
US20220275367A1
(en)
|
2019-07-24 |
2022-09-01 |
Voyager Therapeutics, Inc. |
Compositions and methods for treating huntington's disease
|
|
WO2021025995A1
(en)
|
2019-08-02 |
2021-02-11 |
Voyager Therapeutics, Inc. |
Aav variants with enhanced tropism
|
|
US20220333133A1
(en)
|
2019-09-03 |
2022-10-20 |
Voyager Therapeutics, Inc. |
Vectorized editing of nucleic acids to correct overt mutations
|
|
US12570998B2
(en)
|
2019-09-09 |
2026-03-10 |
Massachusetts Eye & Ear Infirmary |
Methods and compositions for modulating the interaction between adeno-associated virus (AAV) and the AAV receptor (AAVR) for altered bio-distribution of AAV
|
|
WO2021050974A1
(en)
|
2019-09-12 |
2021-03-18 |
The Broad Institute, Inc. |
Engineered adeno-associated virus capsids
|
|
CN114787179A
(zh)
|
2019-10-10 |
2022-07-22 |
坚固生物科技公司 |
经修饰的aav衣壳及其用途
|
|
AU2020368539A1
(en)
|
2019-10-16 |
2022-04-28 |
Massachusetts Institute Of Technology |
Engineered muscle targeting compositions
|
|
US20220403414A1
(en)
*
|
2019-10-16 |
2022-12-22 |
Wuxi Apptec (Shanghai) Co., Ltd. |
Novel aav variant
|
|
CN114729009A
(zh)
|
2019-10-31 |
2022-07-08 |
伯尔尼大学 |
用于眼部基因递送的aav载体变体
|
|
PH12022551247A1
(en)
|
2019-11-22 |
2023-11-13 |
Childrens Hospital Philadelphia |
Adeno-associated viral vector variants
|
|
WO2021108468A1
(en)
|
2019-11-25 |
2021-06-03 |
University Of Florida Research Foundation, Incorporated |
Novel aav3b variants that target human hepatocytes in the liver of humanized mice
|
|
IL293397A
(en)
|
2019-12-04 |
2022-07-01 |
Sangamo Therapeutics Inc |
New preparations and methods for the production of recombinant aav
|
|
AU2021206256A1
(en)
|
2020-01-10 |
2022-07-28 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for delivery of immunotherapy agents across the blood-brain barrier to treat brain cancer
|
|
WO2021150850A1
(en)
|
2020-01-24 |
2021-07-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Svcs. |
Adeno-associated viruses and their uses for inner ear therapy
|
|
US20210261625A1
(en)
|
2020-01-29 |
2021-08-26 |
Genzyme Corporation |
Modified adeno-associated viral capsid proteins for ocular gene therapy and methods of use thereof
|
|
WO2021154923A2
(en)
|
2020-01-29 |
2021-08-05 |
Voyager Therapeutics, Inc. |
Methods and systems for producing aav particles
|
|
EP3868875A1
(en)
|
2020-02-20 |
2021-08-25 |
Medizinische Hochschule Hannover |
Viral vector particle based on aav2 for gene therapy
|
|
TW202142554A
(zh)
|
2020-02-25 |
2021-11-16 |
澳洲兒童醫學研究所 |
腺相關病毒蛋白殼多肽及載體
|
|
WO2021183825A1
(en)
|
2020-03-12 |
2021-09-16 |
California Institute Of Technology |
Adeno-associated viral capsids with expanded sizes
|
|
CN111349148A
(zh)
|
2020-03-13 |
2020-06-30 |
辉大(上海)生物科技有限公司 |
一种腺相关病毒载体及其用途
|
|
EP4121443A4
(en)
|
2020-03-20 |
2024-05-15 |
Dignity Health |
METHOD FOR THE PRODUCTION AND ISOLATION OF ADENO-ASSOCIATED VIRUS
|
|
WO2021202494A1
(en)
|
2020-03-31 |
2021-10-07 |
University Of Massachusetts |
Aav capsids variants and uses thereof
|
|
WO2021202651A1
(en)
|
2020-04-01 |
2021-10-07 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
|
WO2021207077A1
(en)
|
2020-04-06 |
2021-10-14 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for ids gene transfer and methods of use thereof
|
|
IL297391A
(en)
|
2020-04-20 |
2022-12-01 |
Tenaya Therapeutics Inc |
An adeno-associated virus with an engineered capsid
|
|
MX2022013462A
(es)
|
2020-04-27 |
2022-11-16 |
4D Molecular Therapeutics Inc |
Variantes, formulaciones y metodos adeno-asociados para suministro pulmonar.
|
|
US20230173102A1
(en)
|
2020-04-28 |
2023-06-08 |
Genethon |
Use of a Synthetic AAV Capsid for Gene Therapy of Muscle and Central Nervous System Disorders
|
|
AU2021264061A1
(en)
|
2020-05-01 |
2022-12-01 |
Massachusetts Institute Of Technology |
Engineered central nervous system compositions
|
|
US20230304033A1
(en)
|
2020-05-04 |
2023-09-28 |
The University Of North Carolina At Chapel Hill |
Modified adeno-associated virus vectors that evade neutralizing antibodies and uses thereof
|
|
US12209251B2
(en)
|
2020-05-05 |
2025-01-28 |
The University Of North Carolina At Chapel Hill |
Modified adeno-associated virus 5 capsids and uses thereof
|
|
AR122013A1
(es)
|
2020-05-05 |
2022-08-03 |
Univ Duke |
Composiciones de virus adenoasociados compatibles entre especies y métodos para su uso
|
|
CN116096734A
(zh)
|
2020-05-13 |
2023-05-09 |
沃雅戈治疗公司 |
Aav衣壳的向性的重定向
|
|
CN116390934A
(zh)
|
2020-05-26 |
2023-07-04 |
塑造治疗公司 |
功能性aav衣壳的高通量工程化
|
|
JP2023528801A
(ja)
|
2020-05-29 |
2023-07-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
バリアントキャプシドを有するアデノ随伴ウイルスビリオン及びその使用方法
|
|
JP2023531281A
(ja)
|
2020-06-25 |
2023-07-21 |
フェリング・ヴェンチャーズ・エスア |
改善されたアデノ随伴ウイルス遺伝子治療ベクター
|
|
CN116209768A
(zh)
|
2020-07-03 |
2023-06-02 |
吉尼松公司 |
用于通过高变区交换工程化新杂合aav衣壳的方法
|
|
TW202217003A
(zh)
|
2020-07-22 |
2022-05-01 |
美商博得學院股份有限公司 |
經改造之肌肉靶向組合物
|
|
CA3192600A1
(en)
|
2020-08-21 |
2022-02-24 |
Capsida, Inc. |
Adeno-associated virus compositions having preferred expression levels
|
|
TW202237850A
(zh)
|
2020-12-01 |
2022-10-01 |
賓州大學委員會 |
具有組織特異性靶向基序的新穎構成物及含有其之組成物
|
|
EP4263574A4
(en)
|
2020-12-16 |
2025-10-22 |
Childrens Medical Res Institute |
AAV CAPSIDS AND VECTORS
|
|
US20240067678A1
(en)
|
2020-12-16 |
2024-02-29 |
Children's Medical Research Institute |
Adeno-associated virus capsids and vectors
|
|
US20240060087A1
(en)
|
2021-01-08 |
2024-02-22 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav
|
|
TW202242124A
(zh)
|
2021-01-14 |
2022-11-01 |
美商史崔德生物公司 |
靶向ｔ細胞之ａａｖ載體
|
|
WO2022173847A2
(en)
|
2021-02-09 |
2022-08-18 |
Affinia Therapeutics Inc. |
Recombinant aavs with improved tropism and specificity
|
|
WO2022212928A1
(en)
|
2021-04-02 |
2022-10-06 |
The Regents Of The University Of California |
Modified viruses and viral particles, methods of making, and uses thereof
|
|
US20230034817A1
(en)
|
2021-04-12 |
2023-02-02 |
Affinia Therapeutics Inc. |
Recombinant aav for treatment of neural disease
|
|
EP4323013A4
(en)
|
2021-04-13 |
2025-06-25 |
Capsida, Inc. |
SELECTED AAV COMPOSITIONS WITH PREFERRED BRAIN ENRICHEMENT
|
|
EP4322974A4
(en)
|
2021-04-13 |
2025-06-25 |
Capsida, Inc. |
Adeno-associated virus compositions having increased brain enrichment
|
|
EP4322976A4
(en)
|
2021-04-13 |
2025-06-25 |
Capsida, Inc. |
AAV COMPOSITIONS WITH HIGH EXPRESSION LEVELS IN THE BRAIN
|
|
WO2022221421A2
(en)
|
2021-04-13 |
2022-10-20 |
Capsida, Inc. |
Aav compositions with high brain expression for treating mucopolysaccharidosis ii
|
|
WO2022222869A1
(zh)
|
2021-04-19 |
2022-10-27 |
信念医药（香港）有限公司 |
重组腺相关病毒及其应用
|
|
CA3216419A1
(en)
|
2021-04-23 |
2022-10-27 |
Greg NACHTRAB |
Tissue-targeted modified aav capsids and methods of use thereof
|
|
WO2022226375A1
(en)
|
2021-04-23 |
2022-10-27 |
Locanabio, Inc. |
Tissue-targeted modified aav capsids and methods of use thereof
|
|
WO2022226301A1
(en)
|
2021-04-23 |
2022-10-27 |
The University Of North Carolina At Chapel Hill |
Chimeric heart tropic aav capsids
|
|
WO2022226294A1
(en)
|
2021-04-23 |
2022-10-27 |
The University Of North Carolina At Chapel Hill |
Chimeric aav5 capsids
|
|
US20240181083A1
(en)
|
2021-04-23 |
2024-06-06 |
University Of Florida Research Foundation, Incorporated |
Aavrh74 vectors for gene therapy of muscular dystrophies
|
|
WO2022229703A2
(en)
|
2021-04-30 |
2022-11-03 |
Takeda Pharmaceutical Company, Ltd. |
New aav8 based immune escaping variants
|
|
EP4330270A2
(en)
|
2021-04-30 |
2024-03-06 |
Takeda Pharmaceutical Company Limited |
Aav8 capsid variants with enhanced liver targeting
|
|
US20240299586A1
(en)
|
2021-05-06 |
2024-09-12 |
The Regents Of The University Of California |
Novel aav serotypes derived from a library screen
|
|
WO2023283962A1
(en)
|
2021-07-16 |
2023-01-19 |
Huigene Therapeutics Co., Ltd. |
Modified aav capsid for gene therapy and methods thereof
|
|
US20240342311A1
(en)
|
2021-07-30 |
2024-10-17 |
University Of Florida Research Foundation, Incorporated |
Engineering aav vectors with improved cns targeting
|
|
US20250090688A1
(en)
|
2021-08-05 |
2025-03-20 |
The Broad Institute, Inc. |
Engineered muscle targeting compositions
|
|
US20240425549A1
(en)
|
2021-08-25 |
2024-12-26 |
Children's Medical Research Institute |
Modified aav capsid polypeptides and vectors
|
|
MX2024002379A
(es)
|
2021-08-25 |
2024-04-29 |
Childrens Medical Res Institute |
Cápsides y vectores de aav modificados.
|
|
WO2023039480A2
(en)
|
2021-09-08 |
2023-03-16 |
The Broad Institute, Inc. |
Engineered central nervous system compositions
|
|
US20240424143A1
(en)
|
2021-09-08 |
2024-12-26 |
The Broad Institute, Inc. |
Engineered muscle and central nervous system compositions
|
|
AU2022360985A1
(en)
|
2021-10-05 |
2024-05-16 |
Massachusetts Institute Of Technology |
Engineered cardiac muscle compositions
|
|
MX2024004217A
(es)
|
2021-10-08 |
2024-06-26 |
Dyno Therapeutics Inc |
Variantes de cápside y métodos de uso de estas.
|